Published in J Transl Med on February 12, 2016
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 22.89
Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med (1999) 17.03
Cancer stem cells. N Engl J Med (2006) 9.63
Cancer stem cells: models and concepts. Annu Rev Med (2007) 8.06
Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc (2007) 7.01
Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res (2009) 6.43
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res (2009) 4.36
Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol (2008) 3.84
Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood (2004) 3.41
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res (2009) 3.28
Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci U S A (2002) 3.12
Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst (2010) 3.08
Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res (2008) 2.82
Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells (2004) 2.80
The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg (2009) 2.51
ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev (2010) 2.07
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res (2002) 2.00
Aldehyde dehydrogenases and their role in carcinogenesis. Crit Rev Biochem Mol Biol (1992) 1.82
Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia (2007) 1.57
Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact (2008) 1.52
Cancer stem cells in lung cancer: Evidence and controversies. Respirology (2013) 1.46
Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res (1984) 1.39
Comparison of hepatic VX2-carcinomas after intra-arterial, intraportal and intraparenchymal tumor cell injection. An angiographic and computed tomographic study in the rabbit. Invest Radiol (1980) 1.19
The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance. Biomed Pharmacother (2013) 1.16
Molecularly targeted therapy for hepatocellular carcinoma. Cancer Sci (2008) 1.15
Molecular genetics of human aldehyde dehydrogenase. Pharmacogenetics (1992) 1.04
Metastatic potential of tumor-initiating cells in solid tumors. Front Biosci (Landmark Ed) (2011) 0.97
Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures. BMC Cancer (2012) 0.91
Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome. Hepatology (2014) 0.91
An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer. BMC Med Genomics (2013) 0.87
Metastatic cancer stem cells: new molecular targets for cancer therapy. Curr Pharm Biotechnol (2011) 0.83
Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines. Vet J (2012) 0.83
Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo. BMC Cancer (2012) 0.81
Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data. Transl Res (2014) 0.80
Aldehyde dehydrogenases in acute myeloid leukemia. Ann N Y Acad Sci (2014) 0.79
Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. Dig Dis (2015) 0.76